Skip to main content
. 2026 Mar 20;14:1696374. doi: 10.3389/fpubh.2026.1696374

Table 2.

Clinical factors associated with antibiotic use among RSV-positive children.

Variable Use of antibiotics in this illness No use of antibiotics in this illness Total = 72 (100%) p-valuea
N = 48 (66.7%) N/ = 24 (33.3%)
Median age/months (IQR) 2.6 (1.5, 6.0) 3.4 (1.6, 5.4) 2.9 (1.6–5.8) 0.716
Age by categories/months (%) 0.867
0–6 36 (65.5) 19 (0.9) 55 (100)
>6–12 6 (66.7) 3 (33.3) 9 (100)
>12 6 (75.0) 2 (25.0) 8 (100)
Sex 0.616
Male 25 (64.1) 14 (35.9) 39 (100)
Female 23 (69.7) 10 (30.3) 33 (100)
Prematurity 0.852
Born preterm 13 (65.0) 7 (35.0) 20 (100)
Born term 35 (67.3) 17 (32.7) 52 (100)
Temperature at presentation/°C 0.127
36–37.5 33 (61.1) 21 (38.9) 54 (100)
>37.5–38.5 11 (91.7) 1 (8.3) 12 (100)
>38.5 4 (66.7) 2 (33.3) 6 (100)
Oxygen saturation at presentation 0.009
95–100% 33 (57.9) 24 (42.1) 57 (100)
94–90% 4 (100) 0 (0) 4 (100)
<90% 11 (100) 0 (0) 11 (100)
Tachypnea on arrival 0.015
Tachypnea 27 (84.4) 5 (15.6) 32 (100)
No tachypnea 19 (51.4) 18 (48.6) 37 (100)
Difficulty in breathing <0.001
Difficulty in breathing 31 (93.9) 2 (6.1) 33 (100)
No difficulty in breathing 17 (43.6) 22 (56.4) 39 (100)
Admission for this illness <0.001
Inpatient 41 (100) 0 (0) 41(100)
Outpatient 7 (22.6) 24 (77.4) 31 (100)
Antibiotic use before the current visit/hospitalization 0.177
Yes 10 (90.9) 1 (9.1) 11 (100)
No 36 (62.1) 22 (37.9) 58 (100)
Antibiotic use after visit/discharge 0.021
Yes 13 (92.9) 1 (7.1) 14 (100)
No 35 (60.3) 23 (39.7) 58 (100)
Co-infection diagnosed or suspectedb 0.129
Yes 11 (84.6) 2 (15.4) 13 (100)
No 37 (62.7) 22 (37.3) 59 (100)

aChi-squared analysis or Fisher’s test for categorical variables, and the Mann–Whitney test for the median age. Statistical significance was set at p ≤ 0.05.

bInclude acute gastroenteritis, sepsis, suspected meningitis, otitis media, conjunctivitis, urinary tract infection, and aspiration pneumonia.